GPhC

FtP concerns hit a record high for second quarter running

GPhC received record 765 complaints in last three months of 2019.

GPhC and PSNI approve a common exam

The General Pharmaceutical Council’s clampdown on rogue online pharmacies appears to be gathering pace.

The GPhC is taking steps to improve its handling of FtP cases after a Government arms-length body identified a number of concerns.

Figures provided by the regulator suggest there may have been a net decrease of 166 community pharmacies last year.

A coroner's report outlined concerns about pharmacists ordering repeat prescriptions without involving patients.

A recent analysis commissioned by GPhC suggests a worrying number of pharmacy businesses are operating at a deficit.

The GPhC is proposing to raise its yearly registration and renewal fees for pharmacy premises from £262 to £365.

A new online guide for patients on what to expect from a pharmacy can be downloaded from the GPhC website.

The GPhC has agreed new education, training requirements and learning outcomes for all pharmacy support roles.

More than a fifth of pharmacists on the GPhC register who responded to a study said they are dissatisfied in their role.

The GPhC has approved new guidance for pharmacist prescribers.

Liam Anstey appointed as GPhC's director for Wales.

The jointly-agreed 10 high level principles set out the good practice expected when prescribing medication online.

The employers behind a second pharmacy apprenticeship proposal have identified themselves.

Google and other search engines need to take more action against websites selling fake medicines, says an IP protection firm.

The GPhC received 16 whistleblowing disclosures between 1 April 2018 and 31 March 2019, a report reveals.

Failure to record errors, not having enough staff and storage issues among reasons for 'not meeting' standards.

Community pharmacies are more likely to fail a GPhC inspection but also account for all pharmacies rated excellent.

The regulator is taking “robust” enforcement action against online pharmacies who inappropriately supply high-risk medicines.